E-Ching Ong

Associate Director, Process Development Lyell Immunopharma

E-Ching Ong, PhD, is Associate Director, Process Development at Lyell Immunopharma, where she focuses on advancing manufacturing processes for next-generation cell therapies. She is a highly qualified scientist with experience in process development in the biologics and cell therapy fields, passionate about understanding and optimizing processes to increase efficiency and robustness. Prior to Lyell, she worked at Universal Cells and Just Biotherapeutics, contributing to optimization of clinical-grade iPSC culture, scale-out, and gene editing to generate off-the-shelf cell therapies. E-Ching earned her PhD in Cell Biology from the University of Oklahoma and holds a BS in Biochemistry and Molecular Biology from Michigan State University.

Seminars

Thursday 17th September 2026
Designing Process Characterization Strategies to Turn Process Knowledge into Predictable Product Success
12:25 pm
  • Unravelling regulatory guidance and process characterization approaches to ensure alignment
  • Outlining Lyell’s process characterization approach characterization
  • Generating actionable data to establish ranges, controls, and a predictable manufacturing process
E-Ching Ong - Lyell Immunopharma - Expert Speaker at the 11th CAR-TCR Summit 2026